详细信息
红芪多糖减缓糖尿病肾病小鼠病程进展的作用机制研究 被引量:20
Study on the effective mechanisms of Hedysarum polybotrys polysacchcaide on delay the development of diabetic nephropathy in mice with diabetic nephropathy
文献类型:期刊文献
中文题名:红芪多糖减缓糖尿病肾病小鼠病程进展的作用机制研究
英文题名:Study on the effective mechanisms of Hedysarum polybotrys polysacchcaide on delay the development of diabetic nephropathy in mice with diabetic nephropathy
作者:祁雪艳[1];金智生[1];关雁[1];魏玉娇[1];朱真灵[1]
第一作者:祁雪艳
机构:[1]甘肃中医学院中医临床学院,兰州730000
第一机构:甘肃中医药大学中医临床学院
年份:2015
卷号:31
期号:7
起止页码:526
中文期刊名:中国临床药理学杂志
外文期刊名:The Chinese Journal of Clinical Pharmacology
收录:CSTPCD;;北大核心:【北大核心2014】;CSCD:【CSCD2015_2016】;
语种:中文
中文关键词:红芪多糖;糖尿病肾病;p38丝裂原活化蛋白激酶;基质金属蛋白酶;db/db小鼠
外文关键词:Hedysarum polybotrys polysacchcaide;diabetic nephropathy;p38 mitogen -activated protein kinase;matrix metalloproteinases;db/db mice
摘要:目的探讨红芪多糖(HPS)对糖尿病肾病db/db小鼠肾的保护机制。方法将50只5周龄的雄性db/db小鼠随机分为5组:高中低3个剂量实验组,替米沙坦对照组,模型组,正常组(10只同周龄的db/m小鼠)。于6周龄时,灌胃给药,连续8周,分别给予200,100,50 mg·kg-1HPS、替米沙坦5 mg·kg-1和等体积0.9%Na Cl。第8周末,收集小鼠24 h尿,检测24 h尿蛋白排泄量后,处死小鼠,眼球取血,分离血清并测定相关指标。结果给药8周后,血肌酐(Scr)和24 h蛋白尿排泄量均较模型组明显降低(P<0.05,P<0.01);血糖、血尿素氮(BUN)、p38丝裂原活化蛋白激酶(P38MAPK)蛋白表达、P38MAPK mRNA表达及基质金属蛋白酶(MMPs)mRNA表达与模型组比较,只有高、中2个剂量HPS组差异有统计学意义(P<0.05)。结论红芪多糖可能通过抑制db/db小鼠肾小球系膜细胞上P38MAPK和MMPs蛋白及mRNA的表达,从而减缓糖尿病肾病的病程进展。
Objective To investigate the protection effect of Hedysarum polybotrys polysacchcaide ( HPS) on early diabetic nephropathy ( DN) in db/db mice.Methods Fifty db/db male mice ( five weeks old ) were randomly divided into five groups:HPS ( low-dose , mid-dose , hing-dose) groups, telmisartan group, model group.Ten db/m mice ( five weeks old ) were employed as normal group.At the beginning of 6 weeks, were respectively given 200,100, and 50 mg · kg -1 HPS; 5 mg· kg-1 telmisartan.The mice in normol group and model group were given 0.9%NaCl by gavege.The 24 hours urine protein were measured after administration 8 weeks and kill the mice with remove blood and serum was isolated from the eye .And the related indexes were evaluated.Results After interventing 8 weeks,compared with model group , serum creatinine ( Scr) 24 hours urine proteinall in HPS and telmisartan groups decreased ( P〈0.05 ).The levels of blood glucose , blood urea nitrogen ( BUN ) , the expression of p 38 mitogen -activated protein kinase ( p38 MAPK ) and matrix metalloproteinases ( MMPs ) mRNA all decreased , but only the high , middle doses groups of HPS were statisti-cally difference ( P 〈0.05 ) .Conclusion Which indicates that HPS&nbsp;could delay the development of DN by inhibiting the P 38MAPK,MMPs protein and mRNA expression in the glomerular mesangial cell membrane.
参考文献:
正在载入数据...